Metraipolis › archive › dc_442991df67d0
Feminizing and masculinizing gender-affirming hormone therapy affects fibrin clot characteristics in opposite directions — Europe PMC PMID:42254455
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42254455
- DOI
- 10.1016/j.rpth.2026.106648
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-07T22:48:33.670Z
- SHA-256 of the archived text
6e6c58d6ef04fac8caa769bdf86a1d11e10fb9829d50a8ca7c505ce111b5807f- Stable URL of this page
https://metraipolis.com/documento/dc_442991df67d0
How to cite
Feminizing and masculinizing gender-affirming hormone therapy affects fibrin clot characteristics in opposite directions — Europe PMC PMID:42254455 — Europe PMC (en), https://europepmc.org/article/MED/42254455 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_442991df67d0 (Metraipolis archive dc_442991df67d0, sha256 6e6c58d6ef04fac8caa769bdf86a1d11e10fb9829d50a8ca7c505ce111b5807f)
BibTeX
@misc{dc442991df67d0,
title = {Feminizing and masculinizing gender-affirming hormone therapy affects fibrin clot characteristics in opposite directions — Europe PMC PMID:42254455},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42254455},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_442991df67d0; sha256 6e6c58d6ef04fac8caa769bdf86a1d11e10fb9829d50a8ca7c505ce111b5807f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42254455. Agents can read the archived copy with the MCP tool read_document.